Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3761764015 | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3761765019 | Benserazide 50 mg and levodopa 200 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 56915401000001119 | Co-beneldopa 50mg/200mg capsules | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Co-beneldopa product | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Central nervous system agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing benserazide and levodopa | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Levodopa | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Benserazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance | Benserazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing only benserazide and levodopa in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Levodopa | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance | Levodopa | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Benserazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | capsule.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Benserazide hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Levodopa | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Benserazide | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Benserazide | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has specific active ingredient | Benserazide hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has specific active ingredient | Levodopa | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has dispensed dose form | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Co-beneldopa | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance | Benserazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Co-beneldopa 50mg/200mg capsule - product | Is a | False | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-beneldopa 50mg/200mg capsules (DE Pharmaceuticals) | Is a | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Madopar 250 capsules (Roche Products Ltd) | Is a | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Madopar 250 capsules (PI) (Waymade Ltd) | Is a | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-beneldopa 50mg/200mg capsules 100 capsule | Is pack of | False | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-beneldopa 50mg/200mg capsules 60 capsule | Is pack of | False | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Madopar 200mg/50mg capsules (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-beneldopa 50mg/200mg capsules 60 capsule | Has VMP | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-beneldopa 50mg/200mg capsules 100 capsule | Has VMP | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-beneldopa 50mg/200mg capsules (Teva UK Ltd) | Is a | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-beneldopa 50mg/200mg capsules (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Madopar 200mg/50mg capsules (Necessity Supplies Ltd) | Is a | True | Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR